Annual Drug Patent Expirations for RESCRIPTOR Rescriptor is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Viiv Hlthcare drug RESCRIPTOR appeared f…
RESCRIPTOR (delavirdine mesylate) Viiv hlthcare Patent: 6,177,101 Expiration: Jun 7, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post …
Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from twelve suppliers. There are twenty…
The post Patent delisted for Purdue Pharma drug OXYCONTIN appeared first …
Annual Drug Patent Expirations for EFFIENT Effient is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post Patent delisted for Eli Lilly drug EFFIENT appeared first on DrugPatentWatch – …
Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post Patent delisted for Teva Branded drug PROAIR DIGIHALER app…
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post Patent delisted for Teva Branded drug PROAIR RESPICLICK …
Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting…
The post Patent delisted for Astellas drug LEXISCAN appeared firs…
RANEXA (ranolazine) Gilead Patent: 6,303,607 Expiration: May 27, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent…
Annual Drug Patent Expirations for GEODON Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from seven suppliers. There are…
The post New patent expiration for Pfizer Inc drug GEODON appeared first on Dru…
Annual Drug Patent Expirations for RANEXA Ranexa is a drug marketed by Gilead and is included in one NDA. It is available from three suppliers. There are ten patents protecting…
The post New patent expiration for Gilead drug RANEXA appeared first on Dr…
Get new actionable insights and updates from BiotechBlog
